Literature DB >> 31949851

IgG4+ plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4.

Xiaowei Chen1,2, Wenwen Sun3, Risheng Lin3, Zhiming Huang2, Weichang Chen1.   

Abstract

Immunoglobulin 4 (IgG4) is commonly considered a hallmark of autoimmune pancreatitis (AIP). Inflammatory bowel disease (IBD) is believed to play a substantial role in the setting of AIP. Toll-like receptor 4 (TLR4) plays an important role in inflammation. The relationship between IgG4 and TLR4 in the process of IBD is incompletely explored. Our study aimed to assess the expression of IgG4 and TLR4 in IBD patients and to find the role of IgG4 and TLR4 in the IBD process. A cohort of 68 IBD patients was enrolled in our study, and 20 healthy persons served as a control group. Intestinal IgG4 positive (IgG4+) plasma cell infiltration was measured by immunohistochemistry. Serum IgG4 and TLR4 levels were measured by ELISA. Fifteen additional features from the patients' general medical information and lab data were also collected to assess the risk factors of IBD activity by logistical analysis. BALB/c mice were used to build a rat IBD model with dextran sulfate sodium (DSS). The TLR4 inhibitor TAK242 was used to regulate the expression of TLR4. The expression of IgG4 and TLR4 in serum was detected by ELISA. The expression of IgG4 and TLR4 in the intestines were assayed with western blot. Our results revealed that the infiltration of IgG4+ plasma cells was higher in IBD patients (14/68 vs 0/20, P<0.05). The incidence of IgG4+ plasma cells in the IBD group (48.5%) was higher than in the control group (33/68 vs 0/20, P<0.05). Serum IgG4 and TLR4 levels in the IBD group were significantly higher compared with the control group (P<0.05). Based on our logistical analysis, three variables: IgG4+ plasma cell infiltration, CRP, and HB were identified as independent risk factors with odds ratios of 10.917, 1.031, and 0.923, respectively (P<0.05). After the TLR4 was suppressed, the infiltration of IgG4+ plasma cells in the intestines decreased significantly, and expression of IgG4 in the serum and intestines was suppressed. This study demonstrated that intestinal IgG4+ plasma cell infiltration was higher in IBD patients than in the control group. IgG4+ cell infiltration is significantly enhanced in ulcerative colitis patients. IgG4+ plasma cell infiltration can be regulated by TLR4, and an increase of IgG4+ plasma cell infiltration, CRP, and anemia are correlated with an increased risk of active IBD. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Crohn’s disease; Immunoglobulin G4; activity; inflammatory bowel disease; toll-like receptor 4; ulcerative colitis

Year:  2018        PMID: 31949851      PMCID: PMC6962960     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease.

Authors:  Neeraj Narula; Monica Vasudev; John K Marshall
Journal:  Dig Dis Sci       Date:  2010-06-03       Impact factor: 3.199

2.  Localization of Toll-like Receptor (TLR) 2 and TLR4 mRNA in the Colorectal Mucosa of Miniature Dachshunds with Inflammatory Colorectal Polyps.

Authors:  N Yokoyama; H Ohta; J Yamazaki; Y Kagawa; O Ichii; N Khoirun; T Morita; T Osuga; S Y Lim; N Sasaki; K Morishita; K Nakamura; M Takiguchi
Journal:  J Comp Pathol       Date:  2017-01-12       Impact factor: 1.311

Review 3.  Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.

Authors:  Avi Levin; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

4.  Increased IgG4+ cells in duodenal biopsies are not specific for autoimmune pancreatitis.

Authors:  Katherine M Cebe; Paul E Swanson; Melissa P Upton; Maria Westerhoff
Journal:  Am J Clin Pathol       Date:  2013-03       Impact factor: 2.493

5.  Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammation.

Authors:  Philana Fernandes; Charlotte O'Donnell; Caitriona Lyons; Jonathan Keane; Tim Regan; Stephen O'Brien; Padraic Fallon; Elizabeth Brint; Aileen Houston
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

6.  Autoimmune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration.

Authors:  Terumi Kamisawa; Pong-Yui Chen; Yuyang Tu; Hitoshi Nakajima; Naoto Egawa
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

7.  Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.

Authors:  Wenping Wang; Tingsong Xia; Xinpu Yu
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

8.  Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.

Authors:  Amit Raina; Dhiraj Yadav; Miguel Regueiro; Alyssa M Krasinskas; Melissa I Saul; Dee Ann M Sapienza; David G Binion; Douglas J Hartman
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 9.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

10.  Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.

Authors:  Nicholas Horton; Xianrui Wu; Jessica Philpott; Ari Garber; Jean-Paul Achkar; Aaron Brzezinski; Bret A Lashner; Bo Shen
Journal:  Dig Dis Sci       Date:  2016-09-12       Impact factor: 3.199

View more
  2 in total

Review 1.  Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Authors:  Marilia L Montenegro; Juan E Corral; Frank J Lukens; Baoan Ji; Paul T Kröner; Francis A Farraye; Yan Bi
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

2.  TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway.

Authors:  Jiajia Wang; Guannan Zhu; Cheng Sun; Kangwei Xiong; Tingting Yao; Yuan Su; Haiming Fang
Journal:  Microb Cell Fact       Date:  2020-08-06       Impact factor: 5.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.